OPA3 and hepatocellular carcinoma: Furthermore, the knockdown of OPA3 (Optic atrophy 3), a MYBL2 target overexpressed and associated with an unfavorable prognosis of HCC patients, reduces glucose uptake, glycolysis and ATP production, and HCC cell growth [59].